Market Indices
Sector Heatmap
AXGN — Axogen, Inc. Common Stock
NasdaqAxogen, Inc. Common Stock
- O
- 39.92
- H
- 39.92
- L
- 36.97
- V
- 3.06M
AXGN — Latest News & Headlines
13 StoriesA passive stake above 5% in Axogen (AXGN) is held through advisory clients. - Stock Titan
A passive stake above 5% in Axogen (AXGN) is held through advisory clients. Stock Titan
Axogen Inc (AXGN) Shares Fall 6.3% -- What GF Score of 66 Tells Investors - GuruFocus
Axogen Inc (AXGN) Shares Fall 6.3% -- What GF Score of 66 Tells Investors GuruFocus
3 Emerging Biotech Stocks With Significant Upside Potential - MarketBeat
3 Emerging Biotech Stocks With Significant Upside Potential MarketBeat
What Is Drawing Attention To Axogen (AXGN)? - Simply Wall Street
What Is Drawing Attention To Axogen (AXGN)? Simply Wall Street
Axogen Completes Acquisition of BioCircuit Technologies, Expanding Peripheral Nerve Repair Portfolio - Quiver Quantitative
Axogen Completes Acquisition of BioCircuit Technologies, Expanding Peripheral Nerve Repair Portfolio Quiver Quantitative
(AXGN) and the Role of Price-Sensitive Allocations - Stock Traders Daily
(AXGN) and the Role of Price-Sensitive Allocations Stock Traders Daily
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), AxoGen (AXGN) and Biohaven Ltd. (BHVN) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), AxoGen (AXGN) and Biohaven Ltd. (BHVN) The Globe and Mail
Form 8K Axogen Inc For: 1 October By Investing.com - Investing.com Nigeria
Form 8K Axogen Inc For: 1 October By Investing.com Investing.com Nigeria
Truist Securities maintains Buy rating on Axogen, $53 price target - TradingView
Truist Securities maintains Buy rating on Axogen, $53 price target TradingView
AXGN Maintains Outperform Rating by Raymond James -- Price Targe - GuruFocus
AXGN Maintains Outperform Rating by Raymond James -- Price Targe GuruFocus
Axogen completes acquisition of BioCircuit Technologies By Investing.com - Investing.com Australia
Axogen completes acquisition of BioCircuit Technologies By Investing.com Investing.com Australia
AxoGen Acquires BioCircuit, Expands Peripheral Nerve Portfolio - TipRanks
AxoGen Acquires BioCircuit, Expands Peripheral Nerve Portfolio TipRanks
AxoGen Stock Stumbles After Breakout Rally Hype - TipRanks
AxoGen Stock Stumbles After Breakout Rally Hype TipRanks